Medical Science News

RSS

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

Cytori Therapeutics today received U.S. Patent No. 7,651,684 (the ‘684 patent) which covers the Company’s methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The ‘684 patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. In addition, the ‘684 patent covers methods for delivering cell-enriched fat grafts to a patient’s breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.

27 Jan 2010

Dr. Shinya Yamanaka to receive the 2010 March of Dimes Prize in Developmental Biology

The scientist who reprogrammed adult cells into embryonic-like stem cells has been chosen to receive the 2010 March of Dimes Prize in Developmental Biology.

27 Jan 2010

Osiris Therapeutics completes enrollment in Prochymal MSC therapy Phase II trial for type 1 diabetes

Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes Research Foundation (JDRF) for completing enrollment in a Phase II clinical trial evaluating Prochymal, an adult mesenchymal stem cell (MSC) therapy, as a treatment for patients recently diagnosed with type 1 diabetes. The milestone is the fourth in a series of payments resulting from JDRF’s partnership with Osiris for the development of a therapy for type 1 diabetes.

27 Jan 2010

Findings may point toward potential therapies for type 2 diabetes

In people who put on a lot of weight, or whose bodies start developing the inability to use insulin effectively that leads toward type 2 diabetes, the pancreas typically ramps up its supply of insulin-generating "beta" cells, at least partly by replication of the existing cells.

27 Jan 2010

People with higher levels of vitamin D less likely to develop bowel cancer

People with higher levels of vitamin D appear to be significantly less likely to develop bowel cancer, a new European study has found.

27 Jan 2010

caprotec bioanalytics launches three new caproKits based on its CCMS technology

caprotec bioanalytics announced today the commercial launch of three new caproKits(TM), enabling the discovery, identification and characterization of proteins belonging to the groups of metallo-proteases, histon-deacetylases and GDP/GTP binding proteins.

27 Jan 2010

FDA approves Victoza to treat type 2 diabetes in some adults

The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.

27 Jan 2010

HZI researchers explore novel therapies to keep the immune system young and functional for healthy aging

By comparing the immune responses of both, young and old mice, to bacterial infection they found that the number of macrophages, one of the major cell populations involved in the elimination of infecting bacteria, decreases rapidly in aged mice. This decline in the number of fighters and the associated weakness of the immune defense may be responsible for the age-associated increase in susceptibility to infections.

27 Jan 2010

NNSA awards $9M for B&W TSG's medical isotope production program

Babcock & Wilcox Technical Services Group, Inc. has been awarded approximately $9 million from the National Nuclear Security Administration (NNSA) for the company’s medical isotope production program. Awarded under a cooperative agreement, the funding will be used for further development of B&W TSG’s patented reactor technology for medical isotope production using low enriched uranium. B&W TSG is an operating unit of The Babcock & Wilcox Company.

27 Jan 2010

Universite de Montreal researchers are developing leptin-based pill to control hunger

A Universit- de Montr-al research team is developing a pill composed of leptin, the protein that tells our brain to stop eating. "Mice deprived of leptin will not stop eating. They become so big they have trouble moving around," says Mo-se Bendayan, a pathology professor at the Universit- de Montr-al Faculty of Medicine who has studied the leptin protein extensively.

27 Jan 2010

Promising results in mice could prevent fatal iron buildup in humans

A new study shows that a protein found in blood alleviates anemia, a condition in which the body's tissues don't get enough oxygen from the blood. In this animal study, injections of the protein, known as transferrin, also protected against potentially fatal iron overload in mice with thalassemia, a type of inherited anemia that affects millions of people worldwide.

27 Jan 2010

Ben-Gurion University lecturer honored with 2010 Krill Prize for Excellence in Scientific Research

Dr. Anne Bernheim, a senior lecturer at the Department of Chemical Engineering of Ben-Gurion University of the Negev, has been awarded a prestigious Krill Prize for Excellence in Scientific Research 2010.

27 Jan 2010

BioOhio launches Annual Scholarship program to promote bioscience career pursuits among students

The connection between higher education and pursuing a bioscience career is without question. The availability of funds for a student to pursue a bioscience education, however, is sometimes less certain.

27 Jan 2010

Findings may yield novel therapeutic strategies for late-stage breast cancer

Researchers from the Boston University School of Medicine (BUSM) have determined how the TGFβ-Smad signaling pathway, which is over activated in late-stage cancers, is responsible for the "epigenetic memory" that maintains unique patterns of regulatory DNA hypermethylation causing silencing of critical genes that facilitate breast cancer progression.

25 Jan 2010

Long-term graft retention is improved through supplementation of fat grafts with ADRCs

Results from Cytori Therapeutics’ preclinical fat grafting study have been published in the February issue of the Annals of Plastic Surgery. This article, entitled “Supplementation of Fat Grafts with Adipose-Derived Regenerative Cells (ADRCs) Improves Long-Term Graft Retention,” examines the science behind cell-enriched autologous fat grafting and its application to cosmetic and reconstructive surgery. The results demonstrate a doubling in graft retention in cell-enriched grafts and provide insight into the mechanisms behind this improvement.

25 Jan 2010

World’s largest repository of correlated genetic genealogical information under creation in Mali

The Utah Arts Council today announced it has selected Faces of Mali, an exhibit of photographs of village life in western Africa, for its 2010 traveling art program. The show, sponsored by Sorenson Molecular Genealogy Foundation (SMGF) and Mali Rising—two Utah-based non-profit organizations—and the Embassy of Mali, opens a window for viewers into a region with a 600-year history as a center for scholarship and trade. The first traveling exhibit is scheduled for Canyon Community Center in Springdale beginning Feb. 4.

25 Jan 2010

Research paves way for future vaccine against gastric adenocarcinoma

Despite a strong response from our immune defence, the body is unable to rid itself of the bacterium Helicobacter pylori. One reason for this is that this bacterium encourages elements of the immune response to remain in tissue, activating the wrong immune cells. Research results that pave the way for a future vaccine are now being published by the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

IntegraGen now offers Fluidigm's IFC technology to French researchers

Fluidigm, the inventor of integrated fluidic circuits (IFCs), has joined with IntegraGen SA, one of France’s leading providers of genetic research testing services, to bring IFC technology to French researchers. IntegraGen will offer premium class services to its customers using the Fluidigm BioMark™ System for Genetic Analysis and the Access Array™ sample preparation system for next-generation sequencing. IntegraGen’s lab will also be a demonstration site for researchers investigating Fluidigm’s technology.

25 Jan 2010

Halozyme Therapeutics and BioAtla sign research collaboration agreement

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the signing of an exclusive, worldwide, contract research collaboration agreement with BioAtla, LLC for the development of novel high throughput recombinant protein screening libraries directed against targets in oncology, aesthetic dermatology and inflammation.

25 Jan 2010

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.

24 Jan 2010

Medical Science News

New U.S. patent broadens Cytori Therapeutics' portfolio covering adipose-derived cell therapies

Dr. Shinya Yamanaka to receive the 2010 March of Dimes Prize in Developmental Biology

Osiris Therapeutics completes enrollment in Prochymal MSC therapy Phase II trial for type 1 diabetes

Findings may point toward potential therapies for type 2 diabetes

People with higher levels of vitamin D less likely to develop bowel cancer

caprotec bioanalytics launches three new caproKits based on its CCMS technology

FDA approves Victoza to treat type 2 diabetes in some adults

HZI researchers explore novel therapies to keep the immune system young and functional for healthy aging

NNSA awards $9M for B&W TSG's medical isotope production program

Universite de Montreal researchers are developing leptin-based pill to control hunger

Promising results in mice could prevent fatal iron buildup in humans

Ben-Gurion University lecturer honored with 2010 Krill Prize for Excellence in Scientific Research

BioOhio launches Annual Scholarship program to promote bioscience career pursuits among students

Findings may yield novel therapeutic strategies for late-stage breast cancer

Long-term graft retention is improved through supplementation of fat grafts with ADRCs

World’s largest repository of correlated genetic genealogical information under creation in Mali

Research paves way for future vaccine against gastric adenocarcinoma

IntegraGen now offers Fluidigm's IFC technology to French researchers

Halozyme Therapeutics and BioAtla sign research collaboration agreement

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News